SMS Lifesciences India Ltd - 540679 - Shareholding for the Period Ended December 31, 2021
SMS Lifesciences India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here13-01-2022
SMS Lifesciences India Ltd - 540679 - Shareholding for the Period Ended December 31, 2021
SMS Lifesciences India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click hereSMS Lifesciences India Ltd - 540679 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Trupti Ranjan MohantyDesignation :- Company Secretary and Compliance OfficerSMS Lifesciences India Ltd - 540679 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2021, as received from M/s. Aarthi Consultants Private Limited, the Registrar and Share Transfer Agent (RTA) of the Company.SMS Lifesciences India Ltd - 540679 - Newspaper Advertisement (Postal Ballot)
Copies of newspaper advertisement.SMS Lifesciences India Ltd - 540679 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
SUBMISSION OF POSTAL BALLOT NOTICE.SMS Lifesciences India Ltd - 540679 - Closure of Trading Window
INTIMATION OF TRADING WINDOW CLOSURE.SMS Lifesciences India Ltd - 540679 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
Disclosure pursuant to disinvestment In Mahi Drugs Private Limited (wholly-owned subsidiary).SMS Lifesciences India Ltd - 540679 - Clarification Letter
Enclosed is the clarification letter pursuant to query sought by NSE.SMS Lifesciences India Ltd - 540679 - Related Party Transactions [H1F22]
Disclosure pursuant to Regulation 23(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.SMS Lifesciences India Ltd - 540679 - Board Meeting Outcome for OUTCOME OF THE BOARD MEETING
Disclosure pursuant to Regulafion 30 of the SEBI (listing Obllgafions and Disclosure Requlremenfs) Regulations, 2015.